Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Color Uniformity Analysis in Coated Tablets – V 2.0

Posted on By

Analytical Method Development: SOP for Color Uniformity Analysis in Coated Tablets – V 2.0

Standard Operating Procedure for Color Uniformity Analysis in Coated Tablets in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/288/2025
Supersedes SOP/AMD/288/2022
Page No. Page 1 of 10
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To define a validated method for assessing the color uniformity of coated tablets using both instrumental colorimetric techniques and visual inspection. The method ensures batch-to-batch consistency

and compliance with product specifications.

2. Scope

This SOP is applicable to the Analytical Method Development and Quality Control departments performing visual or instrumental analysis of color variation across coated tablets during development, manufacturing, and stability testing.

3. Responsibilities

  • Analytical Scientist: Develops and standardizes the procedure for color uniformity assessment.
  • QC Analyst: Conducts routine testing using visual and/or instrumental techniques.
  • QA Executive: Reviews documentation and ensures compliance with appearance specifications.
See also  Analytical Method Development: SOP for Calibration of UV-Visible Spectrophotometer - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring consistent methodology and color acceptance criteria, in line with regulatory and internal standards.

5. Procedure

5.1 Sample Preparation

  1. Collect 30 coated tablets randomly from the batch (representing all layers of the container).
  2. Wipe gently with lint-free cloth to remove surface dust if needed.
  3. Do not expose to bright light or moisture prior to analysis.

5.2 Visual Inspection (Preliminary)

  1. Arrange tablets on a clean white background under standardized lighting (e.g., D65 daylight simulator).
  2. Observe for any visible color variation, spots, streaks, or non-uniform coating.
  3. Record observations against predefined categories (e.g., acceptable, slight variation, reject).

5.3 Instrumental Color Measurement

  1. Use a calibrated colorimeter or spectrophotometer in reflectance mode.
  2. Set color space as CIE L*a*b* or HunterLab as per internal specification.
  3. Measure L*, a*, b* values for each tablet at three different orientations (top, bottom, side).
  4. Calculate average and standard deviation for all 30 units.
See also  Analytical Method Development: Identification of Impurities in API - V 2.0

5.4 Acceptance Criteria

  • No tablet should show significant visual defects like discoloration, non-uniform coating, or chipping.
  • Colorimeter:
    • ∆E (total color difference) between tablets ≤ 1.5 (acceptable)
    • Standard deviation of L*, a*, b* values ≤ 1.0

5.5 Validation Parameters

  1. Repeatability: Perform three replicates on same tablet set, RSD ≤ 2%
  2. Instrument Calibration: Confirm with standard white and color tiles before use
  3. Robustness: Evaluate at different lighting temperatures (D65, TL84, CWF)

6. Abbreviations

  • ∆E: Total color difference
  • CIE: Commission Internationale de l’Éclairage
  • L*: Lightness
  • a*: Red-green axis
  • b*: Yellow-blue axis

7. Documents

  1. Tablet Color Uniformity Log – Annexure-1
  2. Colorimeter Output Summary – Annexure-2
  3. Visual Inspection Checklist – Annexure-3

8. References

  • USP <1061>: Color Uniformity of Dosage Forms
  • ICH Q6A: Specifications – Test Procedures and Acceptance Criteria
  • CIE Publication No. 15: Colorimetry (3rd Edition)

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Vinita Joshi Pradeep Malhotra Sunita Reddy
Designation Analytical Chemist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Tablet Color Uniformity Log

Tablet ID L* a* b* ∆E Status
CU-288-01 72.1 4.5 18.2 1.2 Pass

Annexure-2: Colorimeter Output Summary

Standard deviation of L* = 0.8, a* = 0.6, b* = 0.5; ∆E between units within acceptable range. No outliers observed.

Annexure-3: Visual Inspection Checklist

Observation Count Remarks
No Defects 28 Uniform appearance
Slight Variation 2 Acceptable under threshold
Rejects 0 None observed

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Integrated ∆E analysis and CIE L*a*b* parameters Annual SOP Review Sunita Reddy
15/11/2022 1.0 Initial SOP Release New SOP QA Head
See also  Analytical Method Development: Moisture Analysis Method for Hygroscopic APIs - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Regulatory Triggers That Demand SOP Updates
Next Post: Site Procedures Conflict with Central SOPs: Audit Risk from Inconsistent Documentation

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version